Cannabis Stratgc Stock Price, News & Analysis
Company Description
Cannabis Stratgc (OTC Link: NUGS) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $36.8K.
NUGS stock has gained 0.0% over the past year. Shares last traded at $0.0012.
This page provides a comprehensive overview of NUGS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cannabis Stratgc (NUGS) stock last traded at $0.0012. At a market capitalization of $36.8K, NUGS is classified as a micro-cap stock with approximately 368.4M shares outstanding.
Latest News
Cannabis Stratgc has 7 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition. View all NUGS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Cannabis Stratgc (NUGS) currently stands at 238 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Cannabis Stratgc (NUGS) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
NUGS Company Profile & Sector Positioning
Cannabis Stratgc (NUGS) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NUGS often look at related companies in the same sector, including Emergent Health (EMGE), Veritas Farms (VFRM), Radiko Holdings (GEATF), Cannonau Corp (CNNC), and Owc Pharmaceutical Resh Corp (OWCP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NUGS's relative position within its industry.